{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:17:41Z","timestamp":1787501861479,"version":"build-2736575974"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Boehringer Ingelheim Pharmaceuticals, Inc would support the page processing\/open-access charges for this article."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Systemic sclerosis (SSc) is a rare and heterogeneous disease affecting the skin and internal organs. SSc-associated ILD (SSc-ILD) is a common and often early manifestation of SSc. This article discusses the rationale for a multidisciplinary approach (MDA) to the early identification and assessment of patients with SSc-ILD. Diagnosis of SSc-ILD is often challenging as patients with early disease can be asymptomatic, and SSc-ILD symptoms, such as exertional dyspnea and cough, are non-specific. High-resolution computed tomography (HRCT) of the lungs is the gold standard for diagnosis of SSc-ILD since pulmonary function tests lack sensitivity and specificity, especially in early disease. On HRCT, most patients with SSc-ILD have a non-specific interstitial pneumonia (NSIP) pattern. In addition, findings of pulmonary hypertension and esophageal dysmotility may be present. The multi-organ involvement of SSc and the diverse spectrum of symptoms support an MDA for the diagnosis and assessment of patients with SSc-ILD, with input from rheumatologists, pulmonologists, gastroenterologists, radiologists, and other specialists.<\/jats:p>\n                  <jats:p>\n                    <jats:table-wrap>\n                      <jats:table>\n                        <jats:tbody>\n                          <jats:tr>\n                            <jats:td align=\"left\" colspan=\"2\">\n                              <jats:bold>Key Points<\/jats:bold>\n                              \u2022\n                              <jats:italic>Interstitial lung disease (ILD) is a common manifestation of systemic sclerosis (SSc).<\/jats:italic>\n                              \u2022\n                              <jats:italic>Early diagnosis is key to reducing the morbidity and mortality associated with SSc-ILD and other manifestations of SSc.<\/jats:italic>\n                              \u2022\n                              <jats:italic>The multi-organ involvement of SSc supports a multidisciplinary approach to the diagnosis and assessment of patients with SSc-ILD, with input from rheumatologists, pulmonologists, gastroenterologists, radiologists, and other specialists.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                        <\/jats:tbody>\n                      <\/jats:table>\n                    <\/jats:table-wrap>\n                  <\/jats:p>","DOI":"10.1007\/s10067-022-06408-4","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T14:03:52Z","timestamp":1666361032000},"page":"653-661","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Viewpoint: a multidisciplinary approach to the assessment of patients with systemic sclerosis-associated interstitial lung disease"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1498-113X","authenticated-orcid":false,"given":"Soumya","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5030-1886","authenticated-orcid":false,"given":"Apostolos","family":"Perelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4892-438X","authenticated-orcid":false,"given":"Ruchi","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9322-2558","authenticated-orcid":false,"given":"Donald F.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8581-1408","authenticated-orcid":false,"given":"Amandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"6408_CR1","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum 65:2737\u20132747. https:\/\/doi.org\/10.1002\/art.38098","journal-title":"Arthritis Rheum"},{"key":"6408_CR2","doi-asserted-by":"publisher","first-page":"A311","DOI":"10.1016\/j.autrev.2009.11.003","volume":"9","author":"B Ranque","year":"2010","unstructured":"Ranque B, Mouthon L (2010) Geoepidemiology of systemic sclerosis. Autoimmun Rev 9:A311\u2013A318. https:\/\/doi.org\/10.1016\/j.autrev.2009.11.003","journal-title":"Autoimmun Rev"},{"key":"6408_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13075-019-1867-1","volume":"21","author":"MR Pokeerbux","year":"2019","unstructured":"Pokeerbux MR, Giovannelli J, Dauchet L et al (2019) Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature. Arthritis Res Ther 21:86. https:\/\/doi.org\/10.1186\/s13075-019-1867-1","journal-title":"Arthritis Res Ther"},{"key":"6408_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/MD.0000000000000018","volume":"93","author":"MA Alba","year":"2014","unstructured":"Alba MA, Velasco C, Simeon CP et al (2014) Early- versus late-onset systemic sclerosis: differences in clinical presentation and outcome in 1037 patients. Medicine (Baltimore) 93:73\u201381. https:\/\/doi.org\/10.1097\/MD.0000000000000018","journal-title":"Medicine (Baltimore)"},{"key":"6408_CR5","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/art.40027","volume":"69","author":"Y Hao","year":"2017","unstructured":"Hao Y, Hudson M, Baron M et al (2017) Early mortality in a multinational systemic sclerosis inception cohort. Arthritis Rheumatol 69:1067\u20131077. https:\/\/doi.org\/10.1002\/art.40027","journal-title":"Arthritis Rheumatol"},{"key":"6408_CR6","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3899\/jrheum.121390","volume":"40","author":"AM Hoffmann-Vold","year":"2013","unstructured":"Hoffmann-Vold AM, Molberg O, Midtvedt O, Garen T, Gran JT (2013) Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis. J Rheumatol 40:1127\u20131133. https:\/\/doi.org\/10.3899\/jrheum.121390","journal-title":"J Rheumatol"},{"key":"6408_CR7","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1136\/ard.2006.066068","volume":"66","author":"VD Steen","year":"2007","unstructured":"Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972\u20132002. Ann Rheum Dis 66:940\u2013944. https:\/\/doi.org\/10.1136\/ard.2006.066068","journal-title":"Ann Rheum Dis"},{"key":"6408_CR8","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall AJ, Bannert B, Vonk M et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69:1809\u20131815. https:\/\/doi.org\/10.1136\/ard.2009.114264","journal-title":"Ann Rheum Dis"},{"key":"6408_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/2397198320903867","volume":"5","author":"SI Nihtyanova","year":"2020","unstructured":"Nihtyanova SI, Denton CP (2020) Pathogenesis of systemic sclerosis associated interstitial lung disease. J Scleroderma Relat Disord 5:6\u201316. https:\/\/doi.org\/10.1177\/2397198320903867","journal-title":"J Scleroderma Relat Disord"},{"key":"6408_CR10","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/art.40815","volume":"71","author":"M Elhai","year":"2019","unstructured":"Elhai M, Hoffmann-Vold AM, Avouac J et al (2019) Performance of candidate serum biomarkers for systemic sclerosis-associated interstitial lung disease. Arthritis Rheumatol 71:972\u2013982. https:\/\/doi.org\/10.1002\/art.40815","journal-title":"Arthritis Rheumatol"},{"key":"6408_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2147\/CLEP.S191418","volume":"11","author":"A Bergamasco","year":"2019","unstructured":"Bergamasco A, Hartmann N, Wallace L, Verpillat P (2019) Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease. Clin Epidemiol 11:257\u2013273","journal-title":"Clin Epidemiol"},{"key":"6408_CR12","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.2147\/CLEP.S191418","volume":"66","author":"SI Nihtyanova","year":"2014","unstructured":"Nihtyanova SI, Schreiber BE, Ong VH et al (2014) Prediction of pulmonary complications and long-term survival in systemic sclerosis. Arthritis Rheumatol 66:1625\u20131635. https:\/\/doi.org\/10.2147\/CLEP.S191418","journal-title":"Arthritis Rheumatol"},{"key":"6408_CR13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/art.41153","volume":"72","author":"SI Nihtyanova","year":"2020","unstructured":"Nihtyanova SI, Sari A, Harvey JC et al (2020) Using autoantibodies and cutaneous subset to develop outcome-based disease classification in systemic sclerosis. Arthritis Rheumatol 72:465\u2013476. https:\/\/doi.org\/10.1002\/art.41153","journal-title":"Arthritis Rheumatol"},{"key":"6408_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163894","volume":"11","author":"VK Jaeger","year":"2016","unstructured":"Jaeger VK, Wirz EG, Allanore Y et al (2016) Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study. PLoS\u00a0One\u00a011:e0163894","journal-title":"PLoS ONE"},{"key":"6408_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102452","volume":"19","author":"C Frantz","year":"2020","unstructured":"Frantz C, Huscher D, Avouac J et al (2020) Outcomes of limited cutaneous systemic sclerosis patients: results on more than 12,000 patients from the EUSTAR database. Autoimmun Rev 19:102452. https:\/\/doi.org\/10.1016\/j.autrev.2019.102452","journal-title":"Autoimmun Rev"},{"key":"6408_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/annrheumdis-2020-217455","volume":"80","author":"AM Hoffmann-Vold","year":"2021","unstructured":"Hoffmann-Vold AM, Allanore Y, Alves M et al (2021) Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database. Ann Rheum Dis 80:219\u2013227. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217455","journal-title":"Ann Rheum Dis"},{"key":"6408_CR17","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","volume":"177","author":"NS Goh","year":"2008","unstructured":"Goh NS, Desai SR, Veeraraghavan S et al (2008) Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 177:1248\u20131254. https:\/\/doi.org\/10.1164\/rccm.200706-877OC","journal-title":"Am J Respir Crit Care Med"},{"key":"6408_CR18","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1164\/rccm.201903-0486OC","volume":"200","author":"AM Hoffmann-Vold","year":"2019","unstructured":"Hoffmann-Vold AM, Fretheim H, Halse AK et al (2019) Tracking impact of interstitial lung disease in systemic sclerosis in a complete nationwide cohort. Am J Respir Crit Care Med 200:1258\u20131266. https:\/\/doi.org\/10.1164\/rccm.201903-0486OC","journal-title":"Am J Respir Crit Care Med"},{"key":"6408_CR19","doi-asserted-by":"publisher","first-page":"274","DOI":"10.36141\/svdld.v36i4.7612","volume":"36","author":"MO Becker","year":"2019","unstructured":"Becker MO, Radic M, Schmidt K et al (2019) Serum cytokines and their predictive value in pulmonary involvement of systemic sclerosis. Sarcoidosis Vasc Diffuse Lung Dis 36:274\u2013284. https:\/\/doi.org\/10.36141\/svdld.v36i4.7612","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"6408_CR20","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/art.40171","volume":"69","author":"M Wu","year":"2017","unstructured":"Wu M, Baron M, Pedroza C et al (2017) CCL2 in the circulation predicts long-term progression of interstitial lung disease in patients with early systemic sclerosis: data from two independent cohorts. Arthritis Rheumatol 69:1871\u20131878. https:\/\/doi.org\/10.1002\/art.40171","journal-title":"Arthritis Rheumatol"},{"key":"6408_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1056\/NEJMoa1114576","volume":"370","author":"L van Bon","year":"2014","unstructured":"van Bon L, Affandi AJ, Broen J et al (2014) Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med 370:433\u2013443. https:\/\/doi.org\/10.1056\/NEJMoa1114576","journal-title":"N Engl J Med"},{"key":"6408_CR22","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1600-0625.2011.01321.x","volume":"20","author":"P Moinzadeh","year":"2011","unstructured":"Moinzadeh P, Krieg T, Hellmich M et al (2011) Elevated MMP-7 levels in patients with systemic sclerosis: correlation with pulmonary involvement. Exp Dermatol 20:770\u2013773. https:\/\/doi.org\/10.1111\/j.1600-0625.2011.01321.x","journal-title":"Exp Dermatol"},{"key":"6408_CR23","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1136\/annrheumdis-2011-200837","volume":"71","author":"M Manetti","year":"2012","unstructured":"Manetti M, Guiducci S, Romano E et al (2012) Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage. Ann Rheum Dis 71:1064\u20131072. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200837","journal-title":"Ann Rheum Dis"},{"key":"6408_CR24","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1002\/art.41020","volume":"71","author":"ER Volkmann","year":"2019","unstructured":"Volkmann ER, Tashkin DP, Kuwana M et al (2019) Progression of interstitial lung disease in systemic sclerosis: the importance of pneumoproteins Krebs von den Lungen 6 and CCL18. Arthritis Rheumatol 71:2059\u20132067. https:\/\/doi.org\/10.1002\/art.41020","journal-title":"Arthritis Rheumatol"},{"key":"6408_CR25","doi-asserted-by":"publisher","first-page":"R50","DOI":"10.1186\/ar3763","volume":"14","author":"M Hudson","year":"2012","unstructured":"Hudson M, Pope J, Mahler M et al (2012) Clinical significance of antibodies to Ro52\/TRIM21 in systemic sclerosis. Arthritis Res Ther 14:R50. https:\/\/doi.org\/10.1186\/ar3763","journal-title":"Arthritis Res Ther"},{"key":"6408_CR26","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1111\/resp.12850","volume":"21","author":"HE Jo","year":"2016","unstructured":"Jo HE, Glaspole IN, Levin KC et al (2016) Clinical impact of the interstitial lung disease multidisciplinary service. Respirology 21:1438\u20131444. https:\/\/doi.org\/10.1111\/resp.12850","journal-title":"Respirology"},{"key":"6408_CR27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pupt.2019.03.012","volume":"56","author":"M Povitz","year":"2019","unstructured":"Povitz M, Li L, Hosein K, Shariff S, Mura M (2019) Implementing an interstitial lung disease clinic improves survival without increasing health care resource utilization. Pulm Pharmacol Ther 56:94\u201399. https:\/\/doi.org\/10.1016\/j.pupt.2019.03.012","journal-title":"Pulm Pharmacol Ther"},{"key":"6408_CR28","doi-asserted-by":"publisher","first-page":"9026171","DOI":"10.1155\/2020\/9026171","volume":"2020","author":"G Ageely","year":"2020","unstructured":"Ageely G, Souza C, De Boer K, Zahra S, Gomes M, Voduc N (2020) The impact of multidisciplinary discussion (MDD) in the diagnosis and management of fibrotic interstitial lung diseases. Can Respir J 2020:9026171. https:\/\/doi.org\/10.1155\/2020\/9026171","journal-title":"Can Respir J"},{"key":"6408_CR29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.36141\/svdld.v36i2.8107","volume":"36","author":"C Biglia","year":"2019","unstructured":"Biglia C, Ghaye B, Reychler G et al (2019) Multidisciplinary management of interstitial lung diseases: a real-life study. Sarcoidosis Vasc Diffuse Lung Dis 36:108\u2013115. https:\/\/doi.org\/10.36141\/svdld.v36i2.8107","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"6408_CR30","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390:1685\u20131699. https:\/\/doi.org\/10.1016\/S0140-6736(17)30933-9","journal-title":"Lancet"},{"key":"6408_CR31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/acr.21583","volume":"64","author":"R Steele","year":"2012","unstructured":"Steele R, Hudson M, Lo E, Baron M, Canadian Scleroderma Research Group (2012) Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis. Arthritis Care Res (Hoboken) 64:519\u2013524. https:\/\/doi.org\/10.1002\/acr.21583","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6408_CR32","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1111\/resp.13084","volume":"22","author":"JZ Cheng","year":"2017","unstructured":"Cheng JZ, Wilcox PG, Glaspole I et al (2017) Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases. Respirology 22:1592\u20131597. https:\/\/doi.org\/10.1111\/resp.13084","journal-title":"Respirology"},{"key":"6408_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13075-018-1735-4","volume":"20","author":"S Hu","year":"2018","unstructured":"Hu S, Hou Y, Wang Q, Li M, Xu D, Zeng X (2018) Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China. Arthritis Res Ther 20:235. https:\/\/doi.org\/10.1186\/s13075-018-1735-4","journal-title":"Arthritis Res Ther"},{"key":"6408_CR34","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1002\/art.39405","volume":"67","author":"YA Suliman","year":"2015","unstructured":"Suliman YA, Dobrota R, Huscher D et al (2015) Brief report: pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease. Arthritis Rheumatol 67:3256\u20133261. https:\/\/doi.org\/10.1002\/art.39405","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"6408_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000820","volume":"14","author":"A Ariani","year":"2019","unstructured":"Ariani A, Silva M, Bravi E et al (2019) Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis. RMD Open 14(5):e000820. https:\/\/doi.org\/10.1136\/rmdopen-2018-000820","journal-title":"RMD Open"},{"key":"6408_CR36","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1055\/s-0039-1684020","volume":"40","author":"A Wells","year":"2019","unstructured":"Wells A, Devaraj A, Renzoni EA et al (2019) Multidisciplinary evaluation in patients with lung disease associated with connective tissue disease. Semin Respir Crit Care Med 40:184\u2013193. https:\/\/doi.org\/10.1055\/s-0039-1684020","journal-title":"Semin Respir Crit Care Med"},{"key":"6408_CR37","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12890-019-1003-7","volume":"19","author":"R Ewert","year":"2019","unstructured":"Ewert R, Ittermann T, Habedank D et al (2019) Prognostic value of cardiopulmonary exercise testing in patients with systemic sclerosis. BMC Pulm Med 19:230. https:\/\/doi.org\/10.1186\/s12890-019-1003-7","journal-title":"BMC Pulm Med"},{"key":"6408_CR38","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3899\/jrheum.170994","volume":"45","author":"G Pugnet","year":"2018","unstructured":"Pugnet G, Marjanovic Z, Deligny C et al (2018) Reproducibility and utility of the 6-minute walk test in systemic sclerosis. J Rheumatol 45:1273\u20131280. https:\/\/doi.org\/10.3899\/jrheum.170994","journal-title":"J Rheumatol"},{"key":"6408_CR39","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/j.1399-6576.2008.01720.x","volume":"52","author":"R Garg","year":"2008","unstructured":"Garg R, Verma S (2008) Pulse oximetry in scleroderma patients: concerns. Acta Anaesthesiol Scand 52:1303\u20131304. https:\/\/doi.org\/10.1111\/j.1399-6576.2008.01720.x","journal-title":"Acta Anaesthesiol Scand"},{"key":"6408_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161908","volume":"11","author":"H Yamakawa","year":"2016","unstructured":"Yamakawa H, Hagiwara E, Kitamura H et al (2016) Clinical features of idiopathic interstitial pneumonia with systemic sclerosis-related autoantibody in comparison with interstitial pneumonia with systemic sclerosis. PLoS\u00a0One\u00a011:e0161908. https:\/\/doi.org\/10.1371\/journal.pone.0161908","journal-title":"PLoS ONE"},{"key":"6408_CR41","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1378\/chest.07-2444","volume":"134","author":"JG Goldin","year":"2008","unstructured":"Goldin JG, Lynch DA, Strollo DC et al (2008) High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. Chest 134:358\u2013367. https:\/\/doi.org\/10.1378\/chest.07-2444","journal-title":"Chest"},{"key":"6408_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226084","volume":"15","author":"L Ebner","year":"2020","unstructured":"Ebner L, Christodoulidis S, Stathopoulou T et al (2020) Meta-analysis of the radiological and clinical features of usual interstitial pneumonia (UIP) and non-specific interstitial pneumonia (NSIP). PLoS\u00a0One\u00a015:e0226084","journal-title":"PLoS ONE"},{"key":"6408_CR43","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1371\/journal.pone.0226084","volume":"33","author":"D Launay","year":"2006","unstructured":"Launay D, Remy-Jardin M, Michon-Pasturel U et al (2006) High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis. J Rheumatol 33:1789\u20131801. https:\/\/doi.org\/10.1371\/journal.pone.0226084","journal-title":"J Rheumatol"},{"key":"6408_CR44","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2214\/AJR.17.18384","volume":"210","author":"JH Chung","year":"2018","unstructured":"Chung JH, Cox CW, Montner SM et al (2018) CT features of the usual interstitial pneumonia pattern: differentiating connective tissue disease-associated interstitial lung disease from idiopathic pulmonary fibrosis. AJR Am J Roentgenol 210:307\u2013313. https:\/\/doi.org\/10.2214\/AJR.17.18384","journal-title":"AJR Am J Roentgenol"},{"key":"6408_CR45","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.2214\/AJR.17.18947","volume":"210","author":"JH Chung","year":"2018","unstructured":"Chung JH, Oldham JM, Montner SM et al (2018) CT-pathologic correlation of major types of pulmonary fibrosis: insights for revisions to current guidelines. AJR Am J Roentgenol 210:1034\u20131041. https:\/\/doi.org\/10.2214\/AJR.17.18947","journal-title":"AJR Am J Roentgenol"},{"key":"6408_CR46","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1136\/ard.2007.081612","volume":"67","author":"MC Vonk","year":"2008","unstructured":"Vonk MC, van Die CE, Snoeren MM et al (2008) Oesophageal dilatation on high-resolution computed tomography scan of the lungs as a sign of scleroderma. Ann Rheum Dis 67:1317\u20131321. https:\/\/doi.org\/10.1136\/ard.2007.081612","journal-title":"Ann Rheum Dis"},{"key":"6408_CR47","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s11926-010-0095-0","volume":"12","author":"D Strollo","year":"2010","unstructured":"Strollo D, Goldin J (2010) Imaging lung disease in systemic sclerosis. Curr Rheumatol Rep 12:156\u2013161. https:\/\/doi.org\/10.1007\/s11926-010-0095-0","journal-title":"Curr Rheumatol Rep"},{"key":"6408_CR48","first-page":"193","volume":"14","author":"D Farrokh","year":"2015","unstructured":"Farrokh D, Abbasi B, Fallah-Rastegar Y, Mirfeizi Z (2015) The extrapulmonary manifestations of systemic sclerosis on chest high resolution computed tomography. Tanaffos 14:193\u2013200","journal-title":"Tanaffos"},{"key":"6408_CR49","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/j.1447-0594.2012.00940.x","volume":"13","author":"K Komiya","year":"2013","unstructured":"Komiya K, Ishii H, Umeki K et al (2013) Computed tomography findings of aspiration pneumonia in 53 patients. Geriatr Gerontol Int 13:580\u2013585. https:\/\/doi.org\/10.1111\/j.1447-0594.2012.00940.x","journal-title":"Geriatr Gerontol Int"},{"key":"6408_CR50","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.semarthrit.2016.02.004","volume":"46","author":"C Richardson","year":"2016","unstructured":"Richardson C, Agrawal R, Lee J et al (2016) Esophageal dilatation and interstitial lung disease in systemic sclerosis: a cross-sectional study. Semin Arthritis Rheum 46:109\u2013114. https:\/\/doi.org\/10.1016\/j.semarthrit.2016.02.004","journal-title":"Semin Arthritis Rheum"},{"key":"6408_CR51","doi-asserted-by":"publisher","first-page":"279","DOI":"10.21037\/cdt.2018.01.10","volume":"8","author":"H Goerne","year":"2018","unstructured":"Goerne H, Batra K, Rajiah P (2018) Imaging of pulmonary hypertension: an update. Cardiovasc Diagn Ther 8:279\u2013296. https:\/\/doi.org\/10.21037\/cdt.2018.01.10","journal-title":"Cardiovasc Diagn Ther"},{"key":"6408_CR52","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1002\/art.34501","volume":"64","author":"S Gunther","year":"2012","unstructured":"Gunther S, Jais X, Maitre S et al (2012) Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension. Arthritis Rheum 64:2995\u20133005. https:\/\/doi.org\/10.1002\/art.34501","journal-title":"Arthritis Rheum"},{"key":"6408_CR53","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1136\/annrheumdis-2014-205637","volume":"73","author":"T Frauenfelder","year":"2014","unstructured":"Frauenfelder T, Winklehner A, Nguyen TD et al (2014) Screening for interstitial lung disease in systemic sclerosis: performance of high-resolution CT with limited number of slices: a prospective study. Ann Rheum Dis 73:2069\u20132073. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205637","journal-title":"Ann Rheum Dis"},{"key":"6408_CR54","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.21037\/jtd.2018.04.39","volume":"10","author":"TDL Nguyen-Kim","year":"2018","unstructured":"Nguyen-Kim TDL, Maurer B, Suliman YA et al (2018) The impact of slice-reduced computed tomography on histogram-based densitometry assessment of lung fibrosis in patients with systemic sclerosis. J Thorac Dis 10:2142\u20132152. https:\/\/doi.org\/10.21037\/jtd.2018.04.39","journal-title":"J Thorac Dis"},{"key":"6408_CR55","doi-asserted-by":"publisher","first-page":"1801164","DOI":"10.1183\/13993003.01164-2018","volume":"53","author":"JH Fisher","year":"2019","unstructured":"Fisher JH, Shapera S, To T et al (2019) Procedure volume and mortality after surgical lung biopsy in interstitial lung disease. Eur Respir J 53:1801164. https:\/\/doi.org\/10.1183\/13993003.01164-2018","journal-title":"Eur Respir J"},{"key":"6408_CR56","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1164\/rccm.2106012","volume":"165","author":"D Bouros","year":"2002","unstructured":"Bouros D, Wells AU, Nicholson AG et al (2002) Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 165:1581\u20131586. https:\/\/doi.org\/10.1164\/rccm.2106012","journal-title":"Am J Respir Crit Care Med"},{"key":"6408_CR57","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1378\/chest.08-0053","volume":"134","author":"A Fischer","year":"2008","unstructured":"Fischer A, Swigris JJ, Groshong SD et al (2008) Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival. Chest 134:601\u2013605. https:\/\/doi.org\/10.1378\/chest.08-0053","journal-title":"Chest"},{"key":"6408_CR58","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/BOR.0000000000000117","volume":"26","author":"DF Kirby","year":"2014","unstructured":"Kirby DF, Chatterjee S (2014) Evaluation and management of gastrointestinal manifestations in scleroderma. Curr Opin Rheumatol 26:621\u2013629. https:\/\/doi.org\/10.1097\/BOR.0000000000000117","journal-title":"Curr Opin Rheumatol"},{"key":"6408_CR59","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4172\/2161-1149.1000235","volume":"8","author":"IM McFarlane","year":"2018","unstructured":"McFarlane IM, Bhamra MS, Kreps A et al (2018) Gastrointestinal manifestations of systemic sclerosis. Rheumatology (Sunnyvale) 8:235. https:\/\/doi.org\/10.4172\/2161-1149.1000235","journal-title":"Rheumatology (Sunnyvale)"},{"key":"6408_CR60","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1093\/rheumatology\/keq147","volume":"49","author":"NM Thoua","year":"2010","unstructured":"Thoua NM, Bunce C, Brough G et al (2010) Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre. Rheumatology (Oxford) 49:1770\u20131775. https:\/\/doi.org\/10.1093\/rheumatology\/keq147","journal-title":"Rheumatology (Oxford)"},{"key":"6408_CR61","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1164\/rccm.200808-1359OC","volume":"179","author":"E Savarino","year":"2009","unstructured":"Savarino E, Bazzica M, Zentilin P et al (2009) Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med 179:408\u2013413. https:\/\/doi.org\/10.1164\/rccm.200808-1359OC","journal-title":"Am J Respir Crit Care Med"},{"key":"6408_CR62","doi-asserted-by":"publisher","first-page":"165","DOI":"10.20524\/aog.2018.0228","volume":"31","author":"K Denaxas","year":"2018","unstructured":"Denaxas K, Ladas SD, Karamanolis GP (2018) Evaluation and management of esophageal manifestations in systemic sclerosis. Ann Gastroenterol 31:165\u2013170. https:\/\/doi.org\/10.20524\/aog.2018.0228","journal-title":"Ann Gastroenterol"},{"key":"6408_CR63","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/1529-0131(200108)45:4<346::AID-ART347>3.0.CO;2-L","volume":"45","author":"I Marie","year":"2001","unstructured":"Marie I, Dominique S, Levesque H et al (2001) Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum 45:346\u2013354. https:\/\/doi.org\/10.1002\/1529-0131(200108)45:4%3c346::AID-ART347%3e3.0.CO;2-L","journal-title":"Arthritis Rheum"},{"key":"6408_CR64","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3899\/jrheum.180940","volume":"47","author":"M Gutierrez","year":"2020","unstructured":"Gutierrez M, Soto-Fajardo C, Pineda C et al (2020) Ultrasound in the assessment of interstitial lung disease in systemic sclerosis: a systematic literature review by the OMERACT Ultrasound Group. J Rheumatol 47:991\u20131000. https:\/\/doi.org\/10.3899\/jrheum.180940","journal-title":"J Rheumatol"},{"key":"6408_CR65","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010566","volume":"97","author":"M Tardella","year":"2018","unstructured":"Tardella M, Di Carlo M, Carotti M et al (2018) Ultrasound B-lines in the evaluation of interstitial lung disease in patients with systemic sclerosis: cut-off point definition for the presence of significant pulmonary fibrosis. Medicine (Baltimore) 97:e0566. https:\/\/doi.org\/10.1097\/MD.0000000000010566","journal-title":"Medicine (Baltimore)"},{"key":"6408_CR66","doi-asserted-by":"publisher","first-page":"E71","DOI":"10.1016\/S2665-9913(19)30144-4","volume":"2","author":"AM Hoffmann-Vold","year":"2020","unstructured":"Hoffmann-Vold AM, Maher TM, Philpot EE et al (2020) The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements. Lancet Rheumatol 2:E71-83. https:\/\/doi.org\/10.1016\/S2665-9913(19)30144-4","journal-title":"Lancet Rheumatol"},{"key":"6408_CR67","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S2213-2600(19)30480-1","volume":"8","author":"A Perelas","year":"2020","unstructured":"Perelas A, Silver RM, Arrossi AV, Highland KB (2020) Systemic sclerosis-associated interstitial lung disease. Lancet Respir Med 8:304\u2013320. https:\/\/doi.org\/10.1016\/S2213-2600(19)30480-1","journal-title":"Lancet Respir Med"},{"key":"6408_CR68","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/BOR.0000000000000795","volume":"33","author":"D Roofeh","year":"2021","unstructured":"Roofeh D, Lescoat A, Khanna D (2021) Treatment for systemic sclerosis-associated interstitial lung disease. Curr Opin Rheumatol 33:240\u2013248. https:\/\/doi.org\/10.1097\/BOR.0000000000000795","journal-title":"Curr Opin Rheumatol"},{"key":"6408_CR69","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2147\/OARRR.S226695","volume":"11","author":"A Fischer","year":"2019","unstructured":"Fischer A, Patel NM, Volkmann ER (2019) Interstitial lung disease in systemic sclerosis: focus on early detection and intervention. Open Access Rheumatol 11:283\u2013307. https:\/\/doi.org\/10.2147\/OARRR.S226695","journal-title":"Open Access Rheumatol"},{"key":"6408_CR70","doi-asserted-by":"publisher","first-page":"175346662110397","DOI":"10.1177\/17534666211039771","volume":"15","author":"AM Nambiar","year":"2021","unstructured":"Nambiar AM, Walker CM, Sparks JA (2021) Monitoring and management of fibrosing interstitial lung diseases: a narrative review for practicing clinicians. Ther Adv Respir Dis 15:1753466621103977. https:\/\/doi.org\/10.1177\/17534666211039771","journal-title":"Ther Adv Respir Dis"},{"key":"6408_CR71","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1093\/rheumatology\/kew488","volume":"56","author":"LA Bissell","year":"2017","unstructured":"Bissell LA, Anderson M, Burgess M et al (2017) Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis. Rheumatology (Oxford) 56:912\u2013921. https:\/\/doi.org\/10.1093\/rheumatology\/kew488","journal-title":"Rheumatology (Oxford)"},{"key":"6408_CR72","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1111\/1756-185X.13331","volume":"21","author":"SO Jeong","year":"2018","unstructured":"Jeong SO, Uh ST, Park S, Kim HS (2018) Effects of patient satisfaction and confidence on the success of treatment of combined rheumatic disease and interstitial lung disease in a multidisciplinary outpatient clinic. Int J Rheum Dis 21:1600\u20131608. https:\/\/doi.org\/10.1111\/1756-185X.13331","journal-title":"Int J Rheum Dis"},{"key":"6408_CR73","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/resp.13913","volume":"26","author":"AEB McLean","year":"2021","unstructured":"McLean AEB, Webster SE, Fry M et al (2021) Priorities and expectations of patients attending a multidisciplinary interstitial lung disease clinic. Respirology 26:80\u201386. https:\/\/doi.org\/10.1111\/resp.13913","journal-title":"Respirology"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06408-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06408-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06408-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T04:06:34Z","timestamp":1676520394000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06408-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["6408"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06408-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]},"assertion":[{"value":"6 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SC, DFK, and AS have nothing to disclose. AP reports consulting fees from Boehringer Ingelheim and United Therapeutics, research funding (for investigator-initiated studies) from Boehringer Ingelheim, and research funding (for sponsor-initiated studies) from Genentech. RY reports fees from Bioclinica, Boehringer Ingelheim, and Genentech.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}